CVS Health Corporation (CVS) EPS Estimated At $1.90

January 20, 2018 - By Louis Casey

 CVS Health Corporation (CVS) EPS Estimated At $1.90
Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported.
Orrstown Fincl Serv reported 2,000 shares. Natl Bank has invested 0.02% in CVS Health Corporation (NYSE:CVS). Private Advisor Limited Liability has invested 0.08% of its portfolio in CVS Health Corporation (NYSE:CVS). Cap City Tru Fl owns 19,741 shares for 0.62% of their portfolio. Altavista Wealth Management holds 1.13% of its portfolio in CVS Health Corporation (NYSE:CVS) for 29,240 shares. Cheviot Value Mngmt Limited Co invested 1.63% of its portfolio in CVS Health Corporation (NYSE:CVS). The Massachusetts-based Adage Cap Prtn Grp Ltd Liability Co has invested 0.36% in CVS Health Corporation (NYSE:CVS). Hartford Management has 236,830 shares for 0.36% of their portfolio. Front Barnett Associates Lc reported 49,667 shares. Visionary Asset Mgmt invested in 4,106 shares. Perkins Coie Tru Company reported 1.15% of its portfolio in CVS Health Corporation (NYSE:CVS). Salem Invest Counselors Inc holds 0.64% in CVS Health Corporation (NYSE:CVS) or 67,934 shares. Atlantic Trust Group Inc Lc has 0.54% invested in CVS Health Corporation (NYSE:CVS) for 1.48M shares. Twin Capital Mngmt Inc owns 110,460 shares. Iberiabank has invested 0.2% of its portfolio in CVS Health Corporation (NYSE:CVS).

Since August 16, 2017, it had 0 buys, and 7 insider sales for $58.32 million activity. $1.67 million worth of CVS Health Corporation (NYSE:CVS) shares were sold by Moriarty Thomas M. Roberts Jonathan C also sold $7.13 million worth of CVS Health Corporation (NYSE:CVS) on Monday, September 18. Shares for $3.22M were sold by Foulkes Helena. Denton David M sold $18.88 million worth of CVS Health Corporation (NYSE:CVS) on Monday, September 11. SWIFT RICHARD J also sold $199,050 worth of CVS Health Corporation (NYSE:CVS) shares.

Analysts expect CVS Health Corporation (NYSE:CVS) to report $1.90 EPS on February, 8.They anticipate $0.19 EPS change or 11.11 % from last quarter’s $1.71 EPS. CVS’s profit would be $1.92B giving it 10.51 P/E if the $1.90 EPS is correct. After having $1.50 EPS previously, CVS Health Corporation’s analysts see 26.67 % EPS growth. The stock increased 0.64% or $0.51 during the last trading session, reaching $79.86. About 7.96M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 20, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 66 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Peer Perform” rating given on Monday, August 14 by Wolfe Research. On Friday, September 8 the stock rating was maintained by Needham with “Hold”. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Monday, December 12. The rating was maintained by Deutsche Bank on Thursday, August 20 with “Hold”. JP Morgan maintained CVS Health Corporation (NYSE:CVS) on Monday, November 2 with “Overweight” rating. Needham maintained it with “Buy” rating and $85.0 target in Monday, December 4 report. The rating was downgraded by Wolfe Research to “Hold” on Wednesday, August 16. The firm has “Buy” rating given on Friday, October 13 by SunTrust. On Tuesday, November 7 the stock rating was maintained by Jefferies with “Hold”. The firm has “Neutral” rating given on Thursday, February 2 by Robert W. Baird.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $80.91 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 16.46 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Prnewswire.com which released: “CVS Health Corporation Announces Quarterly Dividend” on December 29, 2017, also Nasdaq.com with their article: “CVS Health Grows in PBM With Rheumatoid Arthritis Program” published on January 18, 2018, Fool.com published: “Is CVS Health Corporation a Buy in 2018?” on January 17, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS Merger Is A Positive Sign” published on January 09, 2018 as well as Nasdaq.com‘s news article titled: “Ex-Dividend Reminder: Clorox, CVS Health and Lowe’s Companies” with publication date: January 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: